Manipulation of valve composition to elucidate the role of collagen in aortic valve calcification.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 3946110)

Published in BMC Cardiovasc Disord on March 01, 2014

Authors

Karien J Rodriguez, Laura M Piechura, Ana M Porras, Kristyn S Masters1

Author Affiliations

1: Department of Biomedical Engineering, University of Wisconsin-Madison, 1550 Engineering Drive, #2152, Madison, WI 53706, USA. kmasters@wisc.edu.

Articles cited by this

The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys (1961) 19.31

Matrix metalloproteinases. J Biol Chem (1999) 12.08

An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem (2004) 4.12

Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation (2001) 3.47

Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res (2006) 2.91

Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update. Circulation (2011) 2.73

Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg (2003) 2.38

Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology (2003) 1.77

Mechanisms of aortic valve calcification. Am J Cardiol (2004) 1.72

Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ Res (2011) 1.61

Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J Am Coll Cardiol (2003) 1.51

Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis. Atherosclerosis (2003) 1.49

Aortic valve cyclic stretch causes increased remodeling activity and enhanced serotonin receptor responsiveness. Ann Thorac Surg (2011) 1.46

Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol (2007) 1.41

Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis (2005) 1.36

An ex vivo study of the biological properties of porcine aortic valves in response to circumferential cyclic stretch. Ann Biomed Eng (2006) 1.34

Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis. Am J Pathol (2001) 1.33

Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med (2007) 1.33

Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation (2002) 1.28

Substrate properties influence calcification in valvular interstitial cell culture. J Heart Valve Dis (2008) 1.28

Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur Heart J (2005) 1.26

Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol (2000) 1.21

Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts. Heart (2003) 1.18

Regulation of valvular interstitial cell calcification by components of the extracellular matrix. J Biomed Mater Res A (2009) 1.17

Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells. Am J Pathol (2008) 1.13

Material-based regulation of the myofibroblast phenotype. Biomaterials (2007) 1.11

Age-related collagen and elastin content of human heart valves. J Gerontol (1967) 1.10

Role of the MAPK/ERK pathway in valvular interstitial cell calcification. Am J Physiol Heart Circ Physiol (2009) 1.08

Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. J Heart Valve Dis (2002) 1.02

Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2-D and 3-D culture environments. Matrix Biol (2010) 1.01

Aortic valve structure-function correlations: role of elastic fibers no longer a stretch of the imagination. J Heart Valve Dis (1997) 1.00

Aortic valve cusp microstructure: the role of elastin. Ann Thorac Surg (1995) 0.92

Design and validation of a novel bioreactor to subject aortic valve leaflets to side-specific shear stress. Ann Biomed Eng (2011) 0.91

Type I and type III collagen synthesis and composition in the valve matrix in aortic valve stenosis. Atherosclerosis (2006) 0.91

Cells, scaffolds and bioreactors for tissue-engineered heart valves: a journey from basic concepts to contemporary developmental innovations. Eur J Cardiothorac Surg (2010) 0.84

Biological matrices and bionanotechnology. Philos Trans R Soc Lond B Biol Sci (2007) 0.80

Design and physical characterization of a synchronous multivalve aortic valve culture system. Ann Biomed Eng (2009) 0.80